HCA

HCA Healthcare, Inc.

Healthcare · Medical - Care Facilities · NYSE

$529.70

Market Cap$95.0B

P/E Ratio16.0

Dividend Yield0.70%

Beta1.36

Employees226,000

Price Chart

Loading chart...

About HCA Healthcare, Inc.

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

https://www.hcahealthcare.com ↗

AI Research Brief

AI Generated

Investment Thesis

Competitive Moat

characterized by its extensive scale economies and regulatory advantages inherent in healthcare operations. The company's large network of 182 hospitals and numerous outpatient facilities creates significant switching costs for patients and insurers, as well as substantial negotiating power with suppliers and payers. This moat is durable over the next 5-10 years as healthcare demand continues to rise, although competitive threats from emerging telehealth platforms and local healthcare providers could challenge HCA's market share.

Growth Engine

Future revenue growth for HCA is expected to come primarily from the expansion of outpatient services and strategic acquisitions. The total addressable market (TAM) for outpatient care is projected to grow substantially, driven by shifting patient preferences towards minimally invasive procedures and cost-effective care options. HCA is increasingly focusing on organic growth through the enhancement of its outpatient facilities while also considering acquisitions to consolidate its market presence. Currently, the company is gaining market share in the outpatient segment, positioning itself favorably against competitors.

Capital Allocation

, focusing on reinvestment in existing facilities and opportunistic acquisitions that enhance service offerings without compromising financial health. While HCA does not currently pay a dividend, the absence of short-term payouts allows for reinvestment into growth initiatives, which aligns with long-term value creation. However, vigilance is warranted regarding potential value-destructive acquisitions or excessive leverage if pursued aggressively.

Valuation Check

With a current stock price of $529.7, HCA's valuation appears relatively high given the P/E is currently unavailable, but historical analyses suggest that the market may be pricing in the company’s strong growth potential and operational efficiencies. Compared to the healthcare sector median, HCA may be perceived as expensive; however, the company’s projected growth trajectory and market dynamics suggest that the current price might not fully reflect its future earnings power. The market could be underestimating HCA's ability to capitalize on the growing outpatient trend, presenting a potential mispricing opportunity.

Key Risks

Regulatory actions could significantly impact reimbursement rates and operational practices, creating uncertainty in profitability margins.
Competitive disruption from innovative healthcare delivery models, including telehealth services, poses a threat to HCA’s traditional hospital-centric revenue streams.
Margin compression due to rising labor costs and supply chain disruptions could adversely affect profitability, especially if not countered by efficiency improvements.

Catalyst Watchlist

Upcoming quarterly earnings reports could reveal insights into revenue growth from outpatient services and overall financial health, potentially driving stock volatility.
Strategic acquisition announcements or partnerships could signal HCA’s commitment to expanding its service offerings and market presence, influencing investor sentiment.
Changes in regulatory policies or reimbursement frameworks could impact the operational landscape, necessitating close monitoring for potential implications on profitability.

This analysis is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.

Research generated 2026-03-01

Related Stocks

Ready to Invest in HCA?

Robinhood

Commission-free trades with no account minimums. Get started in minutes.

Trade on Robinhood →

Webull

Advanced tools and extended hours trading. Free stock on sign-up.

Trade on Webull →

We may earn a commission if you open an account through our links, at no extra cost to you.

← View in Stock Screener

Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms